US Biologic today announces a partnership with BARDA DRIVe to develop oral influenza vaccines, increasing access to these life-saving technologies. US Biologic joins DRIVe’s “Beyond the Needle” portfolio of companies developing alternative technologies to transform vaccine administration, making vaccines more widely available and eliminating the need for needles, syringes, vials, and cold-chain distribution burdens.
- August 9: The Murfreesboro Post
- August 9: Kingsport Times News
- August 9: News-Herald
- August 9: Daily Post-Athenian
- August 9: Advocate and Democrat
- August 9: Elk Valley Times
- August 9: Johnson City Press
- August 9: Rogersville Review
- August 9: Newport Plain Talk